These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6139547)

  • 1. Which beta-blocker in pregnancy-induced hypertension?
    Lardoux H; Gerard J; Blazquez G; Flouvat B
    Lancet; 1983 Nov; 2(8360):1194. PubMed ID: 6139547
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol.
    Lardoux H; Gerard J; Blazquez G; Chouty F; Flouvat B
    Eur Heart J; 1983 Nov; 4 Suppl G():35-40. PubMed ID: 6662119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of arterial hypertension in the pregnant woman with labetalol. A propos of 24 cases].
    Dubois D; Petitcolas J; Temperville B; Klepper A; Leboullenger P
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):691-700. PubMed ID: 6520355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of 2 beta-blockers on arterial hypertension during pregnancy. Results of a prospective study on 56 pregnant hypertensive women treated with atenolol and labetalol].
    Gérard J; Blazquez G; Lardoux H; Beauséjour B; Faurie C; Rousset D; Flouvat B
    J Gynecol Obstet Biol Reprod (Paris); 1983; 12(8):891-900. PubMed ID: 6672083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of labetalol in pregnancy.
    Riley AJ
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S53-9. PubMed ID: 6169960
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
    J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared.
    Walker JJ; Greer I; Calder AA
    Postgrad Med J; 1983; 59 Suppl 3():168-70. PubMed ID: 6647203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulatory and metabolic effects of a combined alpha- and beta-adrenoceptor blocker (labetalol) in hypertension of pregnancy.
    Lunell NO; Hjemdahl P; Fredholm BB; Nisell H; Persson B; Wager J
    Br J Clin Pharmacol; 1981 Sep; 12(3):345-8. PubMed ID: 7295464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker subtypes and risk of low birth weight in newborns.
    Duan L; Ng A; Chen W; Spencer HT; Lee MS
    J Clin Hypertens (Greenwich); 2018 Nov; 20(11):1603-1609. PubMed ID: 30267456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of labetalol in the treatment of severe hypertension during pregnancy.
    Michael CA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):211S-215S. PubMed ID: 526403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers for pregnancy hypertension.
    Smith AM
    Lancet; 1983 Mar; 1(8326 Pt 1):708-9. PubMed ID: 6132065
    [No Abstract]   [Full Text] [Related]  

  • 12. Labetalol: the nineteen-eighties.
    Robertson JI
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):137S-141S. PubMed ID: 7093098
    [No Abstract]   [Full Text] [Related]  

  • 13. Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.
    Prichard BN; Richards DA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):239S-244S. PubMed ID: 526408
    [No Abstract]   [Full Text] [Related]  

  • 14. Labetalol for the treatment of hypertension in pregnancy. Pharmacokinetics and effects on the uteroplacental blood flow.
    Nylund L; Lunell NO; Lewander R; Sarby B; Thornström S
    Acta Obstet Gynecol Scand Suppl; 1984; 118():71-3. PubMed ID: 6587732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labetalol, a combined alpha- and beta-blocker, in hypertension of pregnancy.
    Lunell NO; Fredholm B; Hjemdahl P; Lewander R; Nisell H; Nylund L; Persson B; Sarby B; Wager J
    Acta Med Scand Suppl; 1982; 665():143-7. PubMed ID: 6961761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the beta 1-adrenoceptor blocker atenolol on antenatal cardiotocography.
    Montan S; Solum T; Sjöberg NO
    Acta Obstet Gynecol Scand Suppl; 1984; 118():99-102. PubMed ID: 6587734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension.
    Lamming GD; Broughton Pipkin F; Symonds EM
    Clin Exp Hypertens (1978); 1980; 2(5):865-95. PubMed ID: 7428566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive therapy in pregnancy.
    Walker H; Bonduelle M; Greer I; Calder AA
    Lancet; 1983 Apr; 1(8330):932-3. PubMed ID: 6132250
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of labetalol and methyldopa in pregnancy-induced hypertension.
    Lamming GD; Symonds EB
    Br J Clin Pharmacol; 1979; 8(Suppl 2):217S-222S. PubMed ID: 526404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of labetalol in the treatment of hypertension complicating pregnancy.
    Michael CA
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):127S-131S. PubMed ID: 7093096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.